Navigation Links
FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
Date:7/8/2011

SILVER SPRING, Md., July 8, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Currently, there are vaccines approved for the prevention of tetanus and diphtheria that can be used in adults 65 and older. Boostrix, which is given as a single-dose booster shot, is the first vaccine approved to prevent all three diseases in older people.

Tetanus can cause paralysis and is caused by bacteria that live in soil, dust, and manure. The bacteria usually enter the body through a deep cut. Diphtheria is a serious bacterial infection that usually causes a bad sore throat, swollen glands, fever, and chills. If not properly diagnosed and treated, serious complications such as heart failure or paralysis can result. Pertussis is a disease that causes uncontrollable coughing; the infected person makes a noise when they breathe after coughing that sounds like "whoop." The incidence of pertussis disease in the United States has been increasing since 2007, with large local outbreaks occurring in 2010 in California, Michigan, and Ohio.

"Pertussis is a highly contagious disease, and outbreaks have occurred among the elderly in nursing homes and hospitals," said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research. "With this approval, adults 65 and older now have the opportunity to receive a vaccine that prevents pertussis, as well as tetanus and diphtheria."  

The safety and effectiveness of Boostrix was based on a study of about 1,300 people ages 65 and older. To demonstrate its ability to protect against pertussis, the antibody levels among participants were measured and found comparable to the levels in infants who received a closely related vacci
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
2. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
3. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
4. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
5. FDA Approves Nulojix for Kidney Transplant Patients
6. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
7. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
8. FDA Approves Redesigned Labels for Some Merck Drugs
9. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
10. FDA Approves Marketing of RMS Subcutaneous Needle Sets
11. FDA Approves Injectable Gel to Treat Fecal Incontinence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "2015 Strategies in ... to their offering. Highlights of the ... of the US tumor marker testing market. ... practice, as well as key economic, regulatory, demographic, ...
(Date:6/3/2015)... -- AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... that their customer, Pharmabox, has introduced the world,s 1 ... over 140 top selling brand name items typically found ... Aid-type store. As published in the ... -based Pharmabox worked with AVT to develop a ...
(Date:6/3/2015)... June 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and license agreement with AbbVie (NYSE: ABBV ... compounds with Halozyme,s ENHANZE ™ platform. ... Halozyme will receive an initial $23 million payment, ... for each of up to nine collaboration targets. ...
Breaking Medicine Technology:United States Strategies in the Tumor Marker Testing Market 2015 2Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) (the "Company") announced ... financing.  The new capital will primarily be used to fund working ... , , ... has been appointed as President, Chief Executive Officer and Board ...
... PRINCETON, N.J. , June 25 Soligenix, ... a late-stage biopharmaceutical company, announced today the publication of ... of Vaccine , which describes protection from mucosal ... of RiVax™, the Company,s vaccine against ricin toxin. The ...
Cached Medicine Technology:Patient Safety Technologies Completes $6.0 Million Equity Financing 2Patient Safety Technologies Completes $6.0 Million Equity Financing 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 4Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 5Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 6Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 7
(Date:6/3/2015)... (PRWEB) June 03, 2015 On the heels ... $13 billion industry by 2020 ( click here to ... computer scientists believe Baltimore has the talent to ... in which genetic code and other biological data are collected ... disease. “Baltimore contains all the elements of a perfect ...
(Date:6/3/2015)... June 03, 2015 Alberto Grignolo, PhD, ... DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program ... of excellence, and commitment to service on a global ... Connector Award that annually recognizes one DIA member for ... the mission of DIA to foster innovation to improve ...
(Date:6/3/2015)... Z-Medica®, LLC, a leading developer and marketer ... designated as National Safety Month by the National Safety ... for its commitment to public safety. , The ... Aid Kits (IFAK) over 100 times in the past ... traffic accidents. Each kit is equipped with what’s needed ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... Implant design can have a profound influence ... bone to an implant surface. The unique triangular-shape of ... encourage bone regeneration, resulting in the gain of greater ... tissues for more esthetic restorations. , “It’s all in ... Implants. The triangular neck of the V3 provides solid ...
Breaking Medicine News(10 mins):Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2
... Area regional provider of hospice and palliative care, and its Foundation have merged ... Board of Directors. , ... Larkspur, CA (PRWEB) February 12, 2009 -- As of January ... hospice and palliative care, and its Foundation have become one entity, under the ...
... Mascara may not be the only thing that can be using ... has arrived. Latisse™ was developed through years of research by Allergan, ... eye care products. , ... Beverly Hills, CA (PRWEB) ...
... Inc., a,leading provider of kidney care services for ... failure, today announced the launch of the,DaVita(R) Glomerular ... and,iPod Touch. Available in over 50 countries in ... German, the DaVita GFR Calculator for,iPhone measures kidney ...
... Division: VETinfo SYSTEMS(TM)DULLES, Va., Feb. 12 RADinfo ... software solutions, proudly introduces a new division: VETinfo ... of RADinfo SYSTEMS , focused solely on ... developed dynamic digital software solutions to enhance patient ...
... An investor group in Trinity,Biotech plc (Nasdaq: ... of,diagnostic products, is delighted that Jim Merselis has joined ... support for Mr. Merselis, the,group has scheduled a conference ... am PT) on Tuesday, February 17, 2009. , ...
... could lead to new treatments for organ,s diseases that ... -- It may be possible to use skin cells ... researchers at the University of Wisconsin-Madison report. , In ... be turned back into stem cells. In this new ...
Cached Medicine News:Health News:Hospice By The Bay and Foundation Merge Under One Governing Board 2Health News:Hospice By The Bay and Foundation Merge Under One Governing Board 3Health News:Make Lashes Longer, Thicker, and Darker with Latisse™ 2Health News:Make Lashes Longer, Thicker, and Darker with Latisse™ 3Health News:DaVita Launches Kidney Calculator for iPhone and iPod Touch 2Health News:DaVita Launches Kidney Calculator for iPhone and iPod Touch 3Health News:RADinfo SYSTEMS(TM) is Pleased to Introduce Their Newly Established Division, VETinfo SYSTEMS(TM) 2
VIKIA Rota-Adeno is a rapid, qualitative, chromatographic immunoassay which simultaneously detects rotaviruses and adenoviruses in stool specimens. Rotaviruses and adenoviruses are responsible for,th...
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: